Global adoption FibriCheck is trusted by over 1 million users across 43 countries and integrated with 2000+ clinical practices, indicating a broad market validation and a ready base for expansion partnerships, channel deals, and regional healthcare collaborations.

Regulatory edge With CE Class IIa certification and regulatory approvals from MHRA, FDA, and TGA, FibriCheck demonstrates strong compliance and can position itself as a trusted software-only cardiac care solution for hospitals, clinics, and connected care programs.

Device-agnostic The software-only, device-agnostic PPG technology works with smartphones and wearables, enabling scalable upsell and integration into existing telehealth, remote monitoring programs, and smartwatch ecosystems.

Strategic partnerships Past collaborations with Inhealthcare/InTechnology PLC and Arrhythmia Alliance illustrate a track record of alliance-building, suggesting opportunities for NHS/NHS-like systems, payer programs, and international health networks.

Data leadership Launch of the FibriCheck Data Registry creates a competitive moat for real-world evidence, enabling co-development, research collaborations, and improved product credibility to attract larger enterprise customers and research sponsors.